AngioDynamics (ANGO) Tops Q1 Views; Raises FY10 Outlook

October 6, 2009 4:04 PM EDT

AngioDynamics (Nasdaq: ANGO) reports Q1 EPS of $0.09, 1 cent better than the analyst estimate of $0.08. Revenue for the quarter was $50.1 million, which compares to the estimate of $47.79 million.

Raises FY10 sales guidance from $209-$215 million to $211-$215 million, which compares to the Street estimate of $209.92 million. FY10 EPS move to $0.45-$0.47, versus the consensus of $0.45.


Related Categories

Earnings
Guidance
Hot List

Stocks Mentioned

ANGO 15.72

-0.03 -0.19%
Volume: 128,228
Track ANGO


Add Your Comment